🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting clinical data in #CMML patients presented at #EHA2024 by #LLSTAP partner Immune-Onc Therapeutics - great work!

Check out the exciting data #LLSTAP partner Kymera Therapeutics presented today at #EHA2024!

Congrats to #LLSTAP partner Faron Pharmaceuticals for completing this important financing round!

🗣️ Breaking ground in pediatric cancer research! This #NationalCancerResearchMonth, we're proud to partner with Adam de Smith, PhD from Keck Medicine of USC, to uncover the roots of acute lymphoblastic leukemia (ALL) in children. Learn more about his efforts 👉 bit.ly/4ezRtOU

Excited to announce a new position for Principal Philanthropy Officer, Life Sciences & Biomedical Investments! An incredible opportunity to work with LLS to enhance our Mission and do more to benefit blood cancer patients. Check out the posting: shorturl.at/vstcE

Congrats to TAP biotech partner RyvuTx on this exciting milestone for patients with LR-MDS!

Congrats to #LLSTAP partner Immune-Onc Therapeutics on their abstract being accepted as an oral presentation for the upcoming #ASH24 meeting - exciting clinical results for patients with CMML!

From research at University of Michigan, to support from The Leukemia & Lymphoma Society, to Kura's clinical expertise— the evolution of our investigational menin inhibitor is an example of true collaboration across academia, advocacy and industry, together for patients with #AML. See our story: kuraoncology.com/perspectives/f…

Please join us and celebrate our 2024 Research grantees! 👏👏👏

#ASH2024 is here! Visit the The Leukemia & Lymphoma Society booth (2122) to learn more about #LLSTAP and #venturephilanthropy along with our scientific and patient community efforts and programs! Thanks to Rgenta Therapeutics and Laurie Adami for participating! Visit the LLS booth to see the full video!

Congratulations on the presentation and thank you for visiting us at the booth at #ASH2024 🤜🩸🤛

What an unforgettable #ASH24! 🎬 ✨ From groundbreaking research presentations to inspiring innovation, this year’s conference highlighted the incredible progress we’re making in advancing care for blood cancer patients and survivors. 🩸💡 We’re inspired by the discoveries

Dr. Stephen Oh from @WUSTL is diving into the causes of chronic myelomonocytic leukemia (CMML)—a rare blood disorder with limited treatment options. His research could lead to new therapies and brighter futures for patients. ❤️ Get the details 👉 bit.ly/4h3mkEj

Nearly 20 years ago, Drs. Grembecka & Cierpicki began pioneering research later supported by The Leukemia & Lymphoma Society & Kura. Today, menin inhibitors that stemmed from their discoveries are being investigated in various genetic subsets of leukemia.​ Watch #FromLabToClinic: kuraoncology.com/perspectives/f…

The recent cuts to lifesaving health research are one of many threats that people with cancer face. We stand with blood cancer patients. ❤️ Read more 👉 bit.ly/4gwjExS

Some diffuse large B-cell lymphoma (DLBCL) patients—specifically African American patients and those with Epstein-Barr virus (EBV)—face worse outcomes. Backed by an LLS-funded grant, Dr. Jean Koff from Winship Cancer Institute of Emory University is working to change that 👉 bit.ly/411z2N7

Progress in action. ❤️ The U.S. FDA has approved a new treatment combination for adults with large B-cell lymphoma, offering hope for those whose cancer has returned or worsened. Get the details 👉 bit.ly/41ulTxf

Thank you The Leukemia & Lymphoma Society for funding our dietary research in newly diagnosed myeloma Memorial Sloan Kettering Cancer Center MSK Department of Medicine Enjoyed chatting with Dr. Gwen Nichols The Leukemia & Lymphoma Society for #MyelomaAwarenessMonth and #WomensHistoryMonth #mmsm Link here: bit.ly/4c5Zx90

We're so excited about our new #LLSTAP partner Solu Therapeutics! Our investment in the Series A helps us advance our mission to improve outcomes for all blood cancers—including rare, serious diseases like #CMML. Learn more 👉lls.org/tap

Look at him go! What can't Stefan Bjelosevic do? He is a rising 🌟of a leukemia scientist and a CDP Fellow, he runs marathons and raises funds for LLS 🩸 Read more about his project here: 👉 lls.org/award/metaboli…